Modulation of alternative splicing as a new treatment for lung cancer. (Q3215663): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Modulation of alternative splicing as a new treatment for lung cancer. | |||
Revision as of 08:36, 12 October 2021
Project Q3215663 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Modulation of alternative splicing as a new treatment for lung cancer. |
Project Q3215663 in Spain |
Statements
49,675.0 Euro
0 references
99,350.0 Euro
0 references
50.0 percent
0 references
1 November 2018
0 references
30 April 2020
0 references
CENTRO DE REGULACION GENOMICA
0 references
41°22'58.40"N, 2°10'38.75"E
0 references
08019
0 references
El cáncer de pulmón es la principal causa de muerte por cáncer en todo el mundo, con muy pocas terapias efectivas. En este proyecto, nosotros proponemos una nueva estrategia para tratar el cáncer de pulmón, gracias al desarrollo de nuestras tecnologías y resultados de consorcios públicos, que nos han permitido identificar nuevas vulnerabilidades al cáncer de pulmón. Hemos desarrollado una nueva familia de productos capaces de corregir una alteración común, presente a les células cancerosas que aumenta su capacidad de crecer. _x000D_ Tenemos resultados, tanto in vitro como in vivo en diferentes modelos de ratón, que demuestran el potencial terapéutico de estos productos y como su uso reduce la velocidad de crecimiento de los tumores. (Spanish)
0 references
Lung cancer is the leading cause of cancer death world-wide with very few effective treatments. In this project, we propose a novel approach for treating lung cancer; thanks to the development of new technologies and the results from public consortiums we have identified a potential vulnerability in lung cancer. We have developed a new family of compounds, capable of correcting a common alteration present in cancer cells that increases their capacity to grow._x000D_ We have results, both in vitro and in vivo in different mouse models, that shows the therapeutic capacities of these compounds and how they reduce the rate at which tumors grow. (English)
0 references
Barcelona
0 references
Identifiers
IU68-009862
0 references